Clivatuzumab
Modify Date: 2024-04-07 09:42:28
Clivatuzumab structure
|
Common Name | Clivatuzumab | ||
|---|---|---|---|---|
| CAS Number | 1622075-09-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ClivatuzumabClivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1]. |
| Name | Research Grade Clivatuzumab (DHD14205) |
|---|
| Description | Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Clivatuzumab 对胰腺导管腺癌 (PDAC) 表现出高特异性，对正常和良性非肿瘤性胰腺组织几乎没有反应性，尽管它对某些其他器官(如胃、结肠、肺)的腺癌表现出有限的反应性(约占所有样本的 10%)[1]。 |
| References |
| No Any Chemical & Physical Properties |